The First 90 Days After Ibogaine: A Recovery Integration Roadmap

Key Takeaways

• Aftercare planning is an important step to prepare before treatment begins. The question “What are my next steps?” should be answered before a patient arrives at the clinic, not after they land back home.
• As federal research has shown, detox alone rarely holds as a lasting method, and detoxification without follow-up treatment generally leads people back to substance use.
• Stress cues tied to people, places, things, and moods are among the most common relapse triggers, which is why returning immediately to an old environment is risky.
• Coping skills are learned skills and are not automatically gained with standard detox methods. Programs such as SMART Recovery teach cravings management and problem-solving through tailored cognitive behavioral techniques.
• A setback provides important information, and a relapse indicates that a plan needs adjusting. It does not mean treatment failed.
• Ninety days is the beginning of lasting treatment, not the end result. Research on continuing care found the strongest outcomes in programs running 12 months or longer with active follow-up.
• No two plans are identical; the success of therapy, relocation, peer support, or structured work depends entirely on the individual and their specific circumstances.

In an observational study of 30 patients who traveled to two clinics in Mexico for ibogaine detoxification, half reported no opioid use at all during the month that followed. The other half used. Same medicine, same protocol, opposite outcomes, and the difference had almost nothing to do with what happened in the treatment room. Rather, it had everything to do with what happened after they had left the facilities. The first 90 days after ibogaine treatment are the period where that split gets decided, and it is the part of the process patients tend to plan for least.

When considering ibogaine as a treatment method, it is important to understand that it is not a cure-all. What it does offer is a head start, particularly for people carrying heavy physical withdrawal, and it opens a period when old patterns feel loosened enough to be examined. What patients build during that period determines whether the change holds. In this guide, we will walk you through what the first 90 days can look like, the potential setbacks, and when to revise a plan that no longer aligns with your current situation, so you can be prepared before you ever start treatment.

What Recovery Integration After Ibogaine Actually Means

Recovery integration is the work of converting what surfaced during treatment into decisions a person makes on an ordinary Tuesday. A patient might leave the clinic with unusual clarity about why they started using, what they have been avoiding, and who they want to be. That clarity is genuinely useful. However, on its own, it changes nothing.

Turning Treatment Experience Into Daily Behavior

Integration is practical. It means new routines, different phone contacts, appointments actually kept, and rehearsed responses for the moments that used to end in use. In one retrospective study of 73 people treated in Mexico, patients who responded well to ibogaine described lasting improvements in their capacity to sit with painful feelings and handle stress. Those are skills, and skills need reps.

Why Detox Alone Rarely Holds

The National Institute on Drug Abuse states the case plainly: detoxification is not the same as treatment, and detoxification without subsequent treatment generally leads to a resumption of drug use. Ibogaine is an unusually effective interruption of withdrawal, yet it sits inside that same rule. A twelve-month follow-up study in New Zealand tracked fourteen participants after a single ibogaine treatment and found sustained reductions in use, though the participants there had ongoing contact with treatment providers who worked alongside other health professionals. Support was part of the design, not a supplementary treatment option.

Build Your 90-Day Plan Before You Leave Treatment

Patients frequently arrive with a detailed picture of the treatment itself and no picture at all of week three back home. That gap causes avoidable relapses. Planning early also gives the clinical team time to flag problems, because a plan that involves moving back in with someone who is actively using is a plan worth revising before anyone books a flight.

Answer the Next Steps Question Early

Whenever possible, settle these questions before treatment begins. Where will you sleep the first month? Who drives you to appointments? What is your income situation, and does your job put you around people who use? Aeden Aeharn, who founded Experience Ibogaine after overcoming severe addiction himself, treats these logistics as part of the medicine rather than paperwork that comes afterward.

Map Your Triggers and Your Support

Write down the specific cues. Not “stress” but the particular street, the particular group chat, the payday, the argument that always precedes a slip. Then name real people who can be called, ranked by who actually answers the phone. Two reliable contacts beat a list of ten vague ones.

Decide Now What Happens If You Slip

Build the response while you are clear-headed, because you will not design a good one mid-craving. A workable plan states who gets called first, what happens in the next hour, and when the treatment team gets looped in. Furthermore, one safety point deserves emphasis here. After a period of abstinence, tolerance drops sharply, so returning to a previous dose can cause an overdose at an amount that was survivable before.

Days 1 Through 30 and Building Stability

The first month is about stabilization, not transformation. Expecting otherwise can lead patients to read normal fatigue as failure.

Give Your Body and Mind Room to Adjust

Patients coming off opiates should expect a gray day after treatment, a stretch of exhaustion and residual withdrawal that medication is provided to ease. Younger patients often move through it quickly, while older patients sometimes need two days. Mood, motivation, sleep, and appetite all wobble during this period. Track them rather than judging them.

Rebuild Structure Into Your Day

Substance use organizes a life, and removing it leaves an addiction-shaped hole that needs filling. Consistent wake times, meals that happen on purpose, movement, and some form of daily responsibility all reduce the empty hours where cravings do their best work. The specifics matter less than the consistency, so plan a schedule that is achievable for the long term.

Ask Whether Your Environment Supports Recovery

This is where the honest conversation happens. Stress cues linked to prior use, meaning particular people, places, things, and moods, rank among the most common triggers for a return to use.

The most striking evidence on this point comes from Lee Robins’ studies of American soldiers returning from Vietnam. Roughly 34% had used heroin during service, and 20% showed symptoms of dependence. In their first year back in the United States, only 1% became re-addicted, though about 10% tried the drug again. Researchers reviewing that work in the journal Addiction caution against leaning on second-hand readings of it, and the veterans’ circumstances differed enormously from those of a patient flying home from Tijuana. Still, the findings suggest that people who left the setting where their use was embedded largely did not resume it.

This is why Experience Ibogaine advises against returning straight to an old home or routine. Time away can create room to adjust to sobriety without every familiar cue arguing against it. That said, we understand that relocation is a luxury for some and impossible for others. Patients with children, custody arrangements, mortgages, or jobs they cannot leave need a different approach, usually built around changing who they see and where they spend unstructured time rather than changing cities.

Begin or Continue Professional Support

Individual therapy, addiction counseling, and psychiatric care for co-occurring conditions each have a role, and the right combination varies. Experience Ibogaine includes two therapy sessions and two ibogaine boosters after patients leave, which covers the transition but is not meant to support a full year of recovery.

When outlining your goals for recovery, set expectations honestly. Therapy is not one-size-fits-all, and a patient may work with someone for a long stretch before the benefit becomes obvious. And research on continuing care supports that in a way clinics rarely admit. For instance, pooled across nineteen controlled trials, continuing care was shown to produce a small but statistically significant benefit, with the strongest results coming from studies running at least twelve months with active effort to keep people engaged. For consistent, statistically defensible care, patience is part of the treatment. But so is switching therapists when the fit is wrong after a fair trial.

Days 31 Through 60 and Developing Coping Skills

By the second month, the immediate physical recovery has mostly settled, and the harder work begins. Old problems are still there that may trigger the desire for relapse, whether it be the mortgage, the marriage, or sheer boredom, so developing skills to fight these triggers is of the utmost importance during this period.

Convert What You Learned Into Action

Take whatever became clear during treatment and turn it into something you can do. If the realization was that isolation precedes every relapse, the action is a standing weekly commitment with other people. If it was that resentment drives use, the action is bringing that specific resentment into therapy. Write down two or three of these triggers and revisit them monthly.

Practice Skills for Cravings and Stress

Cravings are survivable, and they pass, but that is only believable once a patient has actually ridden a few out successfully.

Practical skills worth building include the following:

• Urge Surfing: Observing a craving as a wave that rises and falls rather than a command requiring action.
• Trigger Mapping: Identifying the chain of events preceding an urge so it can be interrupted earlier.
• Stress Regulation: Sleep, exercise, and breathing work that lower baseline reactivity.
• Setback Response: A rehearsed plan for a bad day that does not depend on willpower alone.

Choose a Recovery Program That Fits You

Experience Ibogaine recommends SMART Recovery, which is built on cognitive behavioral therapy and motivational interviewing. Its four-point program covers building motivation, coping with urges, managing thoughts and feelings, and lifestyle balance. Meetings run online as well as in person, which helps patients who have relocated.

However, though it is a recommended recovery option, it is also important to be upfront about the evidence backing this method. A systematic review identified only about twelve studies on SMART Recovery, mostly cross-sectional, with mixed findings when compared against established twelve-step programs. The underlying methods also have stronger support than the mutual-aid package itself. Plenty of patients prefer twelve-step programs, and plenty do better in individual therapy alone. Fit predicts attendance, and attendance predicts benefit.

Consider a Structured Environment

Filling your days with purposeful work keeps you busy and rebuilds self-respect at the same time. For patients who need distance from home without the cost of another residential program, Experience Ibogaine points toward WWOOF, which places people on organic farms where food and housing are exchanged for weekday work. It is a low-cost route to a new routine in a new place, well away from an old social scene. Volunteering, trade programs, and returning to school serve a similar function for those that prefer other methods.

Days 61 Through 90 and Strengthening What Works

The final stretch is for auditing rather than adding. Most patients by now have evidence about what is holding and what is decorative.

Review Progress and Adjust Your Supports

Look honestly at the last 60 days. Which appointments did you actually attend? Which triggers still land hard? Where did you white-knuckle something instead of using a skill? Bring the answers to your therapist or counselor and change the plan accordingly. Adjustment is the point, and a plan that has never been revised is usually a plan nobody is following.

Reinforce Your Support Network

Recovery relationships need maintenance like any others. Keep the contact regular rather than crisis-driven, since calling someone for the first time in eight weeks during a craving rarely goes well. Accountability works best when it is boring and scheduled.

Clarify What You Want to Build

Avoiding substances is a floor, a beginning point. At some stage in recovery, the question becomes what the sober life is actually for, and patients who cannot answer it tend to drift and fall back into old patterns. Career direction, repairing specific relationships, physical health, education, and creative work all give the abstinence something to serve. This is worth revisiting deliberately around day 75, when there is enough stability to think past the next week and instead plan for the future.

Where Psychedelic Integration Fits After Ibogaine

Psychedelic integration is the structured processing of a psychedelic experience so that it produces durable change. For ibogaine patients, this usually means therapeutic work on the content that came up during treatment, alongside the behavioral changes described above.

What Integration Work Involves

Good integration work is specific to the individual. A patient revisits what surfaced, tests it against their history, and decides what it demands of them. Therapists familiar with psychedelic experiences tend to handle this better than those who read the after-effects as symptoms, so it is worth asking a prospective therapist directly about their experience.

Why Some Patients Explore Additional Psychedelic Therapy

Experience Ibogaine supports patients continuing with other psychedelic therapy where it is appropriate, on the reasoning that psychedelics offer a way to check yourself and your ego against a different perspective. There is also a documented basis for it. Ego dissolution, a temporary loss of the ordinary sense of self, is one of the most frequently reported features of 5-MeO-DMT (a psychedelic found in plant species and the venom of the Colorado River toad), and the compound acts fast, with effects generally lasting 15 to 30 minutes rather than the seven or eight hours typical of classic psychedelics. That short duration makes it far easier to pair with a therapy session.

However, when considering this treatment option, keep in mind that outcome data is still early and mostly self-reported. In a survey of 362 adults using 5-MeO-DMT in structured group settings, 80% of those who had been diagnosed with depression and 79% of those diagnosed with anxiety reported improvement, while 3% and 2% respectively reported worsening. Improvement tracked with the intensity and personal meaning of the experience, not with how difficult it was. Additionally, a retrospective study of 51 Special Operations Forces veterans who received ibogaine followed by 5-MeO-DMT in Mexico reported large self-reported reductions in suicidal ideation, PTSD symptoms, depression, and anxiety.

So, while these methods do show promise, the honest caveats do matter. These are surveys, case reports, and open-label studies rather than controlled trials. For instance, one published case report of sequential ibogaine and 5-MeO-DMT for alcohol use disorder recorded great improvement at one month, followed by a partial return to mild drinking at two months. The experience itself can be hard to navigate, with fear, extreme anxiety, and paranoia all documented. None of this makes additional psychedelic therapy a requirement, and it is unsuitable for patients with active psychotic disorders or uncontrolled cardiac conditions. Screening and clinical judgment decide it, patient by patient.

What to Do If Cravings or Relapse Follow Ibogaine

Cravings during the first 90 days after ibogaine are common and do not signal that treatment failed. A return to use is more serious and calls for an immediate reassessment, not a verdict.

Treat a Setback as Information

Relapse rates for substance use disorders run between 40% and 60%, which sits below the 50% to 70% range for hypertension and asthma. Yet nobody concludes that blood pressure medication does not work. Federal guidance treats a relapse as a signal to resume, modify, or change treatment, not abandon it as an unchangeable failure. The useful questions in these situations are diagnostic, not punitive, and may include: What preceded it? Which support was missing or unused? What needs to change now?

Contact Your Treatment Team Right Away

Speed matters more than anything else here, because the gap between a slip and a return to support predicts how bad the episode gets. Call your therapist, your counselor, or the clinic where you are receiving treatment. Recovery management models built around proactive check-ins exist specifically to shorten that gap. And given the overdose risk that follows any period of abstinence, medical contact after a return to opioid use is a safety issue rather than an optional step.

The Follow-Up Option at Experience Ibogaine

Experience Ibogaine offers patients continued access to 5-MeO-DMT follow-up treatment when it is clinically appropriate, including well past the original treatment window. If something difficult happens six months out and a patient finds themselves slipping, the clinic’s position is that they should call to arrange it rather than wait. No other clinic offers this on the same terms.

This access comes with two important conditions. First, treatment is not guaranteed on request, as it depends strictly on medical clearance and suitability. Second, it is one component of an aftercare plan, not a replacement for it.

Why a Second Full Ibogaine Dose Is Not the Answer

Only one full ibogaine dose is safe within a three- to four-month period, which is why patients receive two smaller boosters after treatment that raise noribogaine levels rather than a second flood dose. This limitation is cardiac in nature. Ibogaine can prolong the QTc interval and, rarely, trigger ventricular arrhythmias including Torsades de Pointes, and these events have been documented at therapeutic doses in people with no prior heart condition. Clearance also depends on CYP2D6 enzyme activity, which varies widely between individuals, so poor metabolizers face higher exposure and higher risk.

Screening and monitoring are what make the risk manageable. A review of ibogaine-associated fatalities documented 33 deaths, clustered around pre-existing cardiovascular disease, concurrent use of opioids or benzodiazepines, and absent or inadequate cardiac screening, mostly in unregulated settings. By contrast, a monitored cohort of 191 patients on continuous telemetry with CYP2D6 genotyping recorded no clinically significant arrhythmias, hospitalizations, or deaths. This is why every Experience Ibogaine patient meets with the head doctor and certain patients require a meeting with a cardiologist during pre-treatment screening, why bloodwork covers full liver function alongside vitamin and electrolyte levels, and why medical staff monitor patients 24/7 in private rooms.

Common Challenges in the First 90 Days After Ibogaine

Most difficulties in this period are predictable, which makes them easier to prepare for:

• Going Straight Back to the Same Environment: The fastest route to re-exposure to every established cue.
• Motivation Fading After a Few Weeks: The clarity following treatment is real, and it does dim, which is exactly why external structure carries the load and keeps you on track.
• Struggling to Find the Right Therapist: Availability, cost, and fit all interfere. Starting the search before treatment removes most of the delay.
• Expecting Ibogaine to Have Solved Everything: Debt, grief, chronic pain, and difficult marriages survive treatment intact.
• Reading a Bad Day as Proof of Failure: Fatigue, low mood, and cravings are features of early recovery rather than evidence against it.
• Isolation: Withdrawing from contact tends to precede relapse and is one of the more reliable warning signs.

A Simple 90-Day Ibogaine Recovery Checklist

Signs Your Recovery Plan Needs to Change

Certain patterns indicate the current plan has stopped working and needs revision with a professional:

• Cravings that are getting stronger or more frequent instead of easing
• Rising contact with people or places tied to previous use
• Mood, sleep, or anxiety deteriorating over several weeks
• Old behaviors returning, including secrecy and lying about small things
• Missed or abandoned appointments and meetings
• Support that exists on paper but not in practice
• Any return to use, however brief

Recovery After Ibogaine Continues Beyond 90 Days

Ninety days is a foundation, the starting point of your new life. Federal research on treatment duration found that participation under 90 days has limited effectiveness and recommends significantly longer engagement to maintain outcomes, while continuing care literature saw its best results in programs lasting a year or more with active follow-up. Patients who understand that going in tend to fare better than those who treat day 90 as a finish line.

What the Longer Arc Looks Like

What that longer arc looks like differs for everyone. Some patients need years of therapy, others taper off after a period of stability, and a few build their recovery mainly around peer support and work. Ibogaine gave you an interruption and some room to think. Life gets built afterward, deliberately, on ordinary days.

Plan Your Next Steps With Your Treatment Team

If you are planning treatment or already home and figuring out next steps, talk with the Experience Ibogaine team about post-treatment planning and the follow-up support available to you. We offer customizable plans catered to your specific situation rather than a one-size-fits-all solution, and we can revise your schedule as your circumstances change. To make care more accessible, we also offer discounts for military veterans and first responders, helping groups more likely to experience high-stress situations and traumatic events get the treatment they need. Contact us today, and let our team help you get started on a wellness journey that considers your long-term health and recovery goals.

This article is educational and does not constitute medical advice. Ibogaine remains a Schedule I controlled substance in the United States, and treatment decisions should be made with qualified medical professionals. If you are struggling with substance use or thoughts of self-harm, please reach out to a licensed clinician or a local support service.

Frequently Asked Questions (FAQs)

References

• National Institute on Drug Abuse. “Treatment and Recovery. Drugs, Brains, and Behavior: The Science of Addiction.” National Institute on Drug Abuse, July, 2020.
• National Institute on Drug Abuse. “Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition).” National Institute on Drug Abuse, January, 2014.
• Blodjett, J. et al. “How Effective Is Continuing Care for Substance Use Disorders? A Meta-Analytic Review.” Journal of Substance Abuse Treatment, September 26, 2013.
• Kingsley Brown, T. et al. “Treatment of Opioid Use Disorder With Ibogaine: Detoxification and Drug Use Outcomes.” The American Journal of Drug and Alcohol Abuse, May 25, 2017.
• Noller, G. et al. “Ibogaine Treatment Outcomes for Opioid Dependence From a Twelve-Month Follow-Up Observational Study.” The American Journal of Drug and Alcohol Abuse, April 12, 2017.
• Hall, W. et al. “Lee Robins’ Studies of Heroin Use Among US Vietnam Veterans.” Addiction, September 20, 2016.
• Hester, R. et al. “Overcoming Addictions and SMART Recovery, an Online and In-Person Mutual Help Group for Problem Drinkers, Part 1: Three-Month Outcomes of a Randomized Controlled Trial.” Journal of Medical Internet Research, July 11, 2013.
• Beck, A. et al. “Systematic Review of SMART Recovery: Outcomes, Process Variables, and Implications for Research.” Psychology of Addictive Behaviors, February, 2017
• Davis, A. et al. “5-Methoxy-N, N-Dimethyltryptamine Used in a Naturalistic Group Setting Is Associated With Unintended Improvements in Depression and Anxiety.” The American Journal of Drug and Alcohol Abuse, March 1, 2019.
• Johns Hopkins Medicine. “Fast-Acting Psychedelic Associated With Improvements In Depression and Anxiety.” Johns Hopkins Medicine, March 18, 2019.
• Ragnhildstveit, A. et al. “5-MeO-DMT for Post-Traumatic Stress Disorder: A Real-World Longitudinal Case Study.” Frontiers in Psychiatry, November 23, 2023.
• Barsuglia, J. et al. “A Case Report SPECT Study and Theoretical Rationale for the Sequential Administration of Ibogaine and 5-MeO-DMT in the Treatment of Alcohol Use Disorder.” Progress in Brain Research, August, 2018.
• Davis, A. et al. “Open-Label Study of Consecutive Ibogaine and 5-MeO-DMT Assisted-Therapy for Trauma-Exposed Male Special Operations Forces Veterans.” The American Journal of Drug and Alcohol Abuse, March 1, 2023.
• Brunt, T. “Rare but Relevant: Ibogaine and Cardiovascular Complications, Prolonged QT Interval and Ventricular Arrhythmias.” Addiction, January 20, 2026.
• Knuijver, T. et al. “Safety of Ibogaine Administration in Detoxification of Opioid-Dependent Individuals: A Descriptive Open-Label Observational Study.” Addiction, February 23, 2021.
• Brzostowicki, D. “Ibogaine for Psychiatric Illness: Federal Policy Push Meets Safety Concerns.” Medscape, April 30, 2026.
• Nieubuurt, B. “HB 4110 Staff Measure Summary: House Committee on Behavioral Health.” 83rd Oregon Legislative Assembly, February 12, 2026.